SCHEMBL22632087

SCHEMBL22632087

CNCCc1cc(=O)oc2cc(OC)ccc12

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP2D6 P10635 2/20 0.76
▸ KDM4E B2RXH2 7/20 0.64
▸ ALDH1A1 P00352 5/20 0.64
▸ HPGD P15428 4/20 0.64
▸ LCK P06239 1/20 0.62
▸ CYP19A1 P11511 3/20 0.60
▸ MTNR1A P48039 1/20 0.59
▸ MTNR1B P49286 1/20 0.59
▸ HSD17B10 Q99714 3/20 0.57
▸ LMNA P02545 1/20 0.57
▸ NPSR1 Q6W5P4 1/20 0.57
▸ GAA P10253 1/20 0.53
▸ CA12 O43570 1/20 0.52
▸ CA1 P00915 1/20 0.52
▸ CA2 P00918 1/20 0.52
▸ CA3 P07451 1/20 0.52
▸ CA4 P22748 1/20 0.52
▸ CA5A P35218 1/20 0.52
▸ CA7 P43166 1/20 0.52
▸ CA9 Q16790 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5022816 0.86 CYP2D6 (1.00) CYP2D6KDM4EALDH1A1HPGDLCK
SCHEMBL24623215 0.86 CYP2D6 (0.63) CYP2D6KDM4EALDH1A1HPGDLCK
SCHEMBL22632322 0.85 MTNR1A (0.82) CYP2D6KDM4EALDH1A1HPGDLCK
SCHEMBL15984893 0.85 KDM4E (0.71) CYP2D6KDM4EALDH1A1HPGDLCK
SCHEMBL9797535 0.83 CYP2D6 (0.68) CYP2D6KDM4EALDH1A1HPGDLCK
SCHEMBL29975674 0.83 CYP2D6 (0.68) CYP2D6KDM4EALDH1A1HPGDLCK
SCHEMBL6439485 0.83 KDM4E (0.69) CYP2D6KDM4EALDH1A1HPGDLCK
SCHEMBL28381712 0.83 KDM4E (0.64) CYP2D6KDM4EALDH1A1HPGDLCK
SCHEMBL6031499 0.83 CYP2D6 (0.76) CYP2D6KDM4EALDH1A1HPGDLCK
SCHEMBL24623214 0.82 MTNR1A (0.64) CYP2D6KDM4EALDH1A1HPGDLCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020223174-A1 COUMARIN-MODIFIED ANDROGENS FOR THE TREATMENT OF PROSTATE CANCER HEALTH RESEARCH, INC. (US) 2020-11-05 — — WO disclosed
Send feedback